ELV price target
Elevance Health Inc. · end-of-day data as of Oct 16, 2026
Elevance Health Inc.
$428.26+13.9%
Buy · 23 analystsPT $436.34 +1.9%
The average price target of the 19 analyst firms that published one in the last 12 months is $436.34 for ELV, 1.9% above the last close of $428.26 on Oct 16, 2026. Targets range from $373.78 to $486.40, with a median of $449.87. Rating consensus: Buy.
Summary
- Target upside+1.9%
- ConsensusBuy
Analyst price targets
Low$373.78
Average$436.34
Median$449.87
High$486.40
Upside+1.9%
19 firms with a target in the last 12 months · last close $428.26 · as of Oct 16, 2026
Mizuho Securities$3922025-11-03
Barclays$3822025-10-22
Bernstein$4132025-10-21
RBC Capital$3502026-02-03
Craig-Hallum$4042026-02-02
Piper Sandler$4042026-02-02
Truist Financial$3852026-02-02
Bernstein$4032026-02-01
Barclays$3862026-01-30
+4 more
Guggenheim$3962026-01-29
UBS$3962026-01-29
Guggenheim$4112026-01-22
Mizuho Securities$4052026-01-09
Wolfe Research$4282026-01-08
Wells Fargo$4132026-01-07
+2 more
Morgan Stanley$4192026-06-04
Mizuho Securities$4252026-05-20
Barclays$4032026-04-24
Guggenheim$3942026-04-24
Leerink Partners$3612026-04-23
Robert W. Baird$3462026-04-23
+2 more
Leerink Partners$3972026-07-17
Barclays$4352026-07-16
Bernstein$4862026-07-16
Goldman Sachs$3762026-07-16
Guggenheim$4332026-07-16
New Street$4742026-07-16
+13 more
Guggenheim$4702026-10-12
Barclays$4742026-10-07
— actual price● bullish target● bearish targethover a dot to see the analysts behind it · wheel or drag to move through time · drag the price axis on the right to stretch it · double-click resets
Strong buy 3 · Buy 12 · Hold 8 · Sell 0 · Strong sell 0